Dr Reddy's Laboratories soars on launching Ramelteon Tablets in US Market

24 Jul 2019 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 2608.10, up by 10.40 points or 0.40% from its previous closing of Rs. 2597.70 on the BSE.

The scrip opened at Rs. 2601.00 and has touched a high and low of Rs. 2609.00 and Rs. 2555.55 respectively. So far 7703 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2965.20 on 02-May-2019 and a 52 week low of Rs. 2035.00 on 24-Jul-2018.

Last one week high and low of the scrip stood at Rs. 2679.55 and Rs. 2555.55 respectively. The current market cap of the company is Rs. 42691.26 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 44.50% and 14.44% respectively.

Dr. Reddy's Laboratories has launched Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The company’s Ramelteon Tablets, are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000. According to IQVIA Health, the Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1230.10 -9.90 (-0.80%)
28-Jan-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.20
Dr. Reddys Lab 1230.10
Cipla 1321.50
Zydus Lifesciences 886.75
Lupin 2129.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×